References
- Grodstein F, Newcomb P A, Stampfer M. Postmenopausal hormone therapy and the risk of colorectal cancer : a review and meta-analysis. Am J Med 1999; 106: 574–582
- Herbert-Croteau N. A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev 1998; 7: 653–659
- Nanda K, Bastian L A, Hasselblad V, Simel D L. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstet Gynecol 1999; 93: 880–888
- Chlebowski R T, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004; 350: 991–1004
- Anderson G L, Limacher M, Assaf A R, et al. Effects of conjugated equine estrogen in postmenopausal women with a hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701–1712
- Johnson J R, Lacey J V, Lazovich D, et al. Menopausal hormone therapy and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2009; 18: 196–203
- Yoshihiro T, Kiyoko K, Ryuichi M, et al. Medroxyprogesterone acetate inhibits proliferation of colon cancer cell lines by modulating cell cycle-related protein expression. Menopause 2008; 15: 442–453